医疗机构药物临床试验经费管理中存在的若干问题及对策研究  

Research on Some Problems and Strategies Existing in the Pharmacy Clinical Test Expense Management in the Medical Institution

作　　者：张朝欣 陈硕 

机构地区：[1]中国医学科学院血液病医院(血液学研究所)财务处,天津300020 [2]中国医学科学院血液病医院(血液学研究所)临床试验研究中心,天津300020

出　　处：《中国卫生产业》2016年第24期177-179,共3页China Health Industry

基　　金：科技部"重大新药创制"科技重大专项子课题(2011ZX09302-007-04)

摘　　要：随着国家和社会对新药研发投入力度不断增加,临床试验中的经费管理成为了医院财务管理的重要内容之一。国家监管部门针对临床试验的经费管理并没有明确规定,各个机构对临床试验经费管理标准并不统一,由此引发一系列的管理问题:如经费收入性质不明确、预算不精细及经费使用审批效率低下等;作者通过分析这些问题发生的原因,提出了相应的对策建议,以期进一步规范临床试验经费的管理,提高临床试验的质量。With the continuous increase of national and social research and investment force of new drugs, the expense management in the clinical test has already been one of the important contents of hospital financial management, the national supervision department has not definitely regulated the expense management in clinical test, and the standards of various institutions for clinical test expense management are not unified, therefore, a series of issues occur such as the unclear expense income property, unrefined budget and low approval efficacy of expense use. The paper analyzes the reasons of these problems and puts forwards the corresponding strategies and suggestions in order to further standardize the clinical test expense management and improve the clinical test quality.

关 键 词：临床试验 经费管理 问题 对策 

分 类 号：R95[医药卫生—药学]